Skip to main content
. 2013 Jul 23;1(5):925–929. doi: 10.3892/mco.2013.157

Table II.

Preliminary clinical data (means ± SD).

Variable Observation group (%) Control group (%)
Efficacy assessment (WHO) 66.8 60.2
 KPS
  Prior to treatment 65.73±9.05 64.00±9.00..
  Following treatment 83.36±11.64 71.64±10.60
Phenotype of CIK cells prior to transfusion
 CD3+
  Prior to culture 56.76±4.54 -
  Following culture 94.67±4.46 -
 CD3+CD56+
  Prior to culture 11.32±2.96 -
  Following culture 32.65±1.12 -

KPS, Karnofsky performance status; CIK, cytokine-induced killer.